KROS Keros Therapeutics, Inc.
Healthcare$11.19-0.27%ClosedMarket Cap: $358.1M
As of 2026-05-25
Insider Statistics (Q2 2026)
Acquisitions
2
Dispositions
1
Buy/Sell Ratio
2.00
Net Shares
+1,000
Shares Acquired
56,000
Shares Disposed
55,000
Total Bought ($)
$1.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Tue May 19 | BIENAIME JEAN JACQUES | director | Buy | 1,000 | $10.58 | 9,450 |
| Fri Apr 17 | BIENAIME JEAN JACQUES | director | Buy | 1,000 | $11.70 | 8,450 |
| Mon Apr 06 | Seehra Jasbir | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 55,000 | $0.30 | 440,708 |
| Fri Mar 27 | Cho Esther | officer: Chief Legal Officer | Sell | 80,000 | $15.52 | 80,000 |
| Wed Mar 11 | Newton Charles W. | director | Sell | 14,788 | $11.35 | 14,788 |
| Wed Mar 11 | Newton Charles W. | director | Sell | 13,215 | $0.00 | 13,215 |
| Wed Mar 11 | Newton Charles W. | Sell | 0 | $0.00 | 0 | |
| Wed Mar 11 | BIENAIME JEAN JACQUES | director | Buy | 2,000 | $11.21 | 7,450 |
| Thu Feb 26 | Seehra Jasbir | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 217,000 | $15.52 | 217,000 |
| Thu Feb 26 | Seehra Jasbir | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 100,000 | $15.52 | 100,000 |
| Thu Feb 26 | Regnante Keith | officer: CHIEF FINANCIAL OFFICER | Sell | 60,000 | $15.52 | 60,000 |
| Fri Feb 20 | Seehra Jasbir | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 7,015 | $16.17 | 385,708 |
| Fri Feb 20 | Lerner Lorena Raquel | officer: Chief Science Officer | Sell | 3,873 | $16.35 | 31,127 |
| Fri Feb 20 | Cho Esther | officer: SVP, General Counsel | Sell | 4,745 | $16.35 | 39,755 |